On the mechanism of CFTR inhibition by a thiazolidinone derivative
暂无分享,去创建一个
Tzyh-Chang Hwang | Yoshiro Sohma | Min Li | Y. Sohma | Z. Kopeikin | T. Hwang | Zoia Kopeikin | Min Li
[1] S. S. Smith,et al. CFTR: mechanism of anion conduction. , 1999, Physiological reviews.
[2] Douglas C. Rees,et al. The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism , 2002, Science.
[3] L. Tsui,et al. Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.
[4] D. Sheppard,et al. Molecular pharmacology of the CFTR Cl- channel. , 1999, Trends in pharmacological sciences.
[5] K. Barrett,et al. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. , 2000, Annual review of physiology.
[6] Hong Yang,et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. , 2002, The Journal of clinical investigation.
[7] R. Dawson,et al. Structure of a bacterial multidrug ABC transporter , 2006, Nature.
[8] C. Armstrong,et al. Ionic pores, gates, and gating currents , 1974, Quarterly Reviews of Biophysics.
[9] Paola Vergani,et al. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains , 2005, Nature.
[10] Jinglan Zhou,et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 , 2009, Proceedings of the National Academy of Sciences.
[11] N. McCarty,et al. Identification of a region of strong discrimination in the pore of CFTR. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[12] R. Aldrich,et al. Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB , 1990, Science.
[13] P. Grootenhuis,et al. Pharmacological Rescue of Mutant CFTR Function for the Treatment of Cystic Fibrosis , 2008 .
[14] K. Locher,et al. Asymmetry in the Structure of the ABC Transporter-Binding Protein Complex BtuCD-BtuF , 2007, Science.
[15] F Bezanilla,et al. Inactivation of the sodium channel. II. Gating current experiments , 1977, The Journal of general physiology.
[16] Tzyh-Chang Hwang,et al. CLC-0 and CFTR: chloride channels evolved from transporters. , 2008, Physiological reviews.
[17] Michael Dean,et al. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. , 2005, Annual review of genomics and human genetics.
[18] G. Nagel,et al. Dual Effects of Adp and Adenylylimidodiphosphate on Cftr Channel Kinetics Show Binding to Two Different Nucleotide Binding Sites , 1999, The Journal of general physiology.
[19] A. Taddei,et al. Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors , 2004, The Journal of general physiology.
[20] A. Aleksandrov,et al. Nucleoside triphosphate pentose ring impact on CFTR gating and hydrolysis , 2002, FEBS letters.
[21] L Csanády,et al. Rapid kinetic analysis of multichannel records by a simultaneous fit to all dwell-time histograms. , 2000, Biophysical journal.
[22] K L Magleby,et al. Estimating kinetic parameters for single channels with simulation. A general method that resolves the missed event problem and accounts for noise. , 1990, Biophysical journal.
[23] On the Mechanism of MgATP-dependent Gating of CFTR Cl− Channels , 2003, The Journal of general physiology.
[24] C. Armstrong. Interaction of Tetraethylammonium Ion Derivatives with the Potassium Channels of Giant Axons , 1971, The Journal of general physiology.
[25] T. Hwang,et al. Probing an Open CFTR Pore with Organic Anion Blockers , 2002, The Journal of general physiology.
[26] A. Verkman,et al. CFTR pharmacology and its role in intestinal fluid secretion. , 2003, Current opinion in pharmacology.
[27] B D Schultz,et al. Pharmacology of CFTR chloride channel activity. , 1999, Physiological reviews.
[28] X. Zou,et al. The Two ATP Binding Sites of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Play Distinct Roles in Gating Kinetics and Energetics , 2006, The Journal of general physiology.
[29] R. Ravazzolo,et al. Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis. , 2008, The Biochemical journal.
[30] J. Ruppersberg,et al. Cloned neuronal Ik(A) channels reopen during recovery from inactivation , 1991, Nature.
[31] T. Hwang,et al. Dual roles of the sixth transmembrane segment of the CFTR chloride channel in gating and permeation , 2010, The Journal of general physiology.
[32] Y. Sohma,et al. G551D and G1349D, Two CF-associated Mutations in the Signature Sequences of CFTR, Exhibit Distinct Gating Defects , 2007, The Journal of general physiology.
[33] Joseph F. Cotten,et al. Cystic Fibrosis-associated Mutations at Arginine 347 Alter the Pore Architecture of CFTR , 1999, The Journal of Biological Chemistry.
[34] K. Locher,et al. Structure of an ABC transporter in complex with its binding protein , 2007, Nature.
[35] M. Welsh,et al. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.
[36] X. Zou,et al. High affinity ATP/ADP analogues as new tools for studying CFTR gating , 2005, The Journal of physiology.
[37] L. Csanády,et al. Degenerate ABC composite site is stably glued together by trapped ATP , 2010, The Journal of general physiology.
[38] T Hoshi,et al. Biophysical and molecular mechanisms of Shaker potassium channel inactivation , 1990, Science.
[39] L. Tsui,et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.
[40] D. Rees,et al. An Inward-Facing Conformation of a Putative Metal-Chelate-Type ABC Transporter , 2007, Science.
[41] Tsung-Yu Chen,et al. Blocking Pore-open Mutants of CLC-0 by Amphiphilic Blockers , 2009, The Journal of general physiology.
[42] R. MacKinnon,et al. Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors , 2001, Nature.
[43] A. Taddei,et al. Altered channel gating mechanism for CFTR inhibition by a high‐affinity thiazolidinone blocker , 2004, FEBS letters.
[44] A. Taddei,et al. Differential Sensitivity of the Cystic Fibrosis (CF)-associated Mutants G551D and G1349D to Potentiators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl– Channel* , 2006, Journal of Biological Chemistry.
[45] K. Locher,et al. Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP , 2007, FEBS letters.
[46] P. Linsdell,et al. Direct Comparison of the Functional Roles Played by Different Transmembrane Regions in the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Pore* , 2004, Journal of Biological Chemistry.
[47] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.
[48] Y. Sohma,et al. State-dependent modulation of CFTR gating by pyrophosphate , 2009, The Journal of general physiology.
[49] D. Sheppard,et al. Gating of the CFTR Cl− channel by ATP‐driven nucleotide‐binding domain dimerisation , 2009, The Journal of physiology.